Literature DB >> 1869836

Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV).

K E Nelson1, D Vlahov, S Cohn, M Odunmbaku, A Lindsay, J C Antohony, E W Hook.   

Abstract

The association between human immunodeficiency virus (HIV) seropositivity and a history of sexually transmitted diseases (STDs), evidence of STDs on physical examination, and sexual and drug use practices was studied in a population of 2921 intravenous drug users (IVDUs) in Baltimore during 1988 and 1989. Overall, 24.1% were HIV-seropositive at baseline, and 60% reported a history of an STD. A significant association was found between HIV seropositivity and a history of syphilis (P = .04); both were more frequent among homosexual/bisexual men than among heterosexual IVDUs. In multivariate analysis, a history of syphilis was independently associated with HIV seroprevalence in homosexual/bisexual male IVDUs, of whom 90% reported a history of sexual intercourse with women. Cocaine injection was independently associated with HIV seropositivity but not a history of syphilis on multivariate analysis. STDs, indicative of unsafe sex practices, are common in this population; efforts are needed to prevent sexual transmission of HIV infection among IVDUs and their sex partners.

Entities:  

Mesh:

Year:  1991        PMID: 1869836     DOI: 10.1093/infdis/164.3.457

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  The relationship between self-reported sexual orientation and behavior in a sample of middle-aged male injection drug users.

Authors:  Thomas Alex Washington; Noya Galai; Sylvia Cohn; David D Celentano; David Vlahov; Steffanie A Strathdee
Journal:  Arch Sex Behav       Date:  2006-02

3.  HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities.

Authors:  A H Kral; R N Bluthenthal; R E Booth; J K Watters
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

Review 4.  STD control in drug users and street youth.

Authors:  A van den Hoek
Journal:  Genitourin Med       Date:  1997-08

5.  A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY.

Authors:  M N Gourevitch; D Hartel; E E Schoenbaum; P A Selwyn; K Davenny; G H Friedland; R S Klein
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

6.  Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6.

Authors:  J López-Zetina; W Ford; M Weber; S Barna; T Woerhle; P Kerndt; E Monterroso
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

7.  Factors associated with sexually transmitted infection underreporting among female sex workers in China.

Authors:  Yan Hong; Xiaoyi Fang; Yuejiao Zhou; Ran Zhao; Xiaoming Li
Journal:  J Womens Health (Larchmt)       Date:  2010-12-31       Impact factor: 2.681

8.  Where injecting drug users receive HIV counseling and testing.

Authors:  R O Valdiserri; T S Jones; G R West; C H Campbell; P I Thompson
Journal:  Public Health Rep       Date:  1993 May-Jun       Impact factor: 2.792

9.  The prevalence and incidence of sexually transmitted infections in a prospective cohort of injection drug users in Vancouver, British Columbia.

Authors:  Laura M Kuyper; Courtney Lc Collins; Thomas Kerr; Robert S Hogg; Kathy Li; Mark W Tyndall; Julio Sg Montaner; Evan Wood
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

10.  A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?

Authors:  E H Kaplan; K Khoshnood; R Heimer
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.